MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacadv.2025.102008

Медицинская библиотека · JACC. Advances · 2025

Feasibility and Prognostic Value of Stress Cardiovascular Magnetic Resonance in Patients With End-Stage Renal Disease.

Rifai Iyad, Ourahma Saida, Broussaud Thomas Ki-Yong, Galichon Pierre, Kachenoura Nadjia, Boussouar Samia, Nguyen Lan-Anh, Charpentier Etienne, Pasi Nicoletta, Chung Cécile, Drouin Sarah, Francois Hélène, Tourret Arnaud Jérôme, Giovachini Louis, Kerneis Mathieu, Montalescot Gilles, Zeitouni Michel, Redheuil Alban

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients with end-stage renal disease (ESRD) are at high cardiovascular risk. The safety and prognostic value of stress cardiovascular magnetic resonance (CMR) in ESRD patients remains unclear as data are lacking due to perceived contrast agent-related risk.

OBJECTIVES

The authors aimed to assess the safety and prognostic value of stress CMR in asymptomatic ESRD patients on waitlist for kidney transplantation.

METHODS

This was an observational single-center cohort study of asymptomatic patients with ESRD (estimated glomerular filtration rate <30 mL/min/1.73 m2 or on dialysis) referred for stress CMR. Patterns of abnormal perfusion and late gadolinium enhancement were classified as typical or atypical for ischemic heart disease. Patients were followed for the occurrence of major adverse cardiovascular events (MACE) and contrast-related complications.

RESULTS

Of 3328 ESRD patients, 845 (age 60 years [53-66], 67% men) were included with a median follow-up of 5.4 years. No major CMR-related adverse events occurred. Abnormal perfusion (12%) and presence of late gadolinium enhancement (22%) were strongly associated with the occurrence of MACE and remained independent of traditional risk factors including prior coronary disease (respectively, aHR: 4.76 [95% CI: 3.34-6.79]; aHR: 3.86 [95% CI: 2.59-5.74]; P < 0.001). Both typical and atypical ischemic heart disease patterns were independently associated with MACE (aHR: 5.68 [95% CI: 3.39-9.52] and aHR: 5.84 [95% CI: 3.82-8.91]; P < 0.001). CMR findings improved prognostic accuracy beyond American Heart Association 2012 risk criteria for ESRD patients (C-statistic improvement: 0.10).

CONCLUSIONS

In ESRD patients, stress CMR is feasible, safe, and adds significant prognostic value for MACE beyond traditional risk factors by characterizing patterns of microvascular and macrovascular disease.

Для цитирования: Rifai Iyad, Ourahma Saida, Broussaud Thomas Ki-Yong, Galichon Pierre, Kachenoura Nadjia, Boussouar Samia, Nguyen Lan-Anh, Charpentier Etienne, Pasi Nicoletta, Chung Cécile, Drouin Sarah, Francois Hélène, Tourret Arnaud Jérôme, Giovachini Louis, Kerneis Mathieu, Montalescot Gilles, Zeitouni Michel, Redheuil Alban. Feasibility and Prognostic Value of Stress Cardiovascular Magnetic Resonance in Patients With End-Stage Renal Disease.. JACC. Advances. 2025. DOI: 10.1016/j.jacadv.2025.102008.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.